Masimo Corporation

MASI

Find Out if You Qualify for a Financial Reward by filling out the form below.

Lead Plaintiff Deadline:
October 23, 2023

Days Left:
-130

calendar

Masimo Corporation Form












Class Action Lawsuit List does not share your information with others. There is no cost or obligation for you to submit.

Allegations

According to the complaint, defendants provided investors with material information concerning Masimo’s revenue and sales for the second quarter of fiscal 2023 and expected revenue for the full-year 2023. Defendants’ statements included, among other things, Masimo’s ability to deliver clinically proven new products to the healthcare markets thereby supporting defendants’ decision to forecast revenue of $550 million to $565 million for the quarter and increase its earnings-per-share estimates to between $3.59 per share and $3.69 per share. Defendants’ statements in this regard prompted an immediate and dramatic increase in the price of Masimo’s common stock. From a closing price of $167.31 per share on February 28, 2023 at the start of the Class Period, Masimo’s stock price climbed to $184.97 per share the following day on March 1, 2023 on unusually high volume. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts. On July 17, 2023 Masimo issued a press release announcing its second quarter 2023 earnings. Defendants announced lower than expected revenue for the second quarter of fiscal 2023 and preliminarily decreased full-year revenue estimates for both healthcare and non-healthcare segments. On this news, the price of Masimo’s common stock declined dramatically. From a closing market price of $147.16 per share on July 17, 2023, Masimo’s stock price fell to $117.73 per share on July 18, 2023, a decline of nearly 20% in the span of just a single day.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Masimo purchased or acquired during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Masimo during the relevant time frame, you have until October 23, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Active Cases

Ticker Symbol Company Name Join Deadline Join
ASRT Assertio Holdings, Inc. March 05, 2024 Join
DADA Dada Nexus Limited March 11, 2024 Join
BNTX BioNTech SE March 12, 2024 Join
MBLY Mobileye Global Inc. March 18, 2024 Join
BIVI BioVie Inc. March 19, 2024 Join
ALVR AlloVir, Inc. March 19, 2024 Join
BTI British American Tobacco p.l.c. March 25, 2024 Join
EVVTY Evolution AB (publ) March 25, 2024 Join
ADM Archer-Daniels-Midland Company March 25, 2024 Join
RILY B. Riley Financial, Inc. March 25, 2024 Join
CART Maplebear Inc. d/b/a Instacart March 25, 2024 Join
EAF GrafTech International Ltd. March 25, 2024 Join
SAVA Cassava Sciences, Inc. April 02, 2024 Join
IRTC iRhythm Technologies, Inc. April 08, 2024 Join
NYCB New York Community Bancorp, Inc. April 08, 2024 Join
HUT Hut 8 Corp. April 08, 2024 Join
XPOF Xponential Fitness, Inc. April 09, 2024 Join
AMLX Amylyx Pharmaceuticals, Inc. April 09, 2024 Join
INMD InMode Ltd. April 15, 2024 Join
AMPL Amplitude, Inc. April 15, 2024 Join
NOVA Sunnova Energy International Inc. April 16, 2024 Join
INOD Innodata Inc. April 22, 2024 Join
DKS DICK's Sporting Goods, Inc. April 22, 2024 Join
FOXF Fox Factory Holding Corp. April 22, 2024 Join
LTRX Lantronix, Inc. April 23, 2024 Join
PANW Palo Alto Networks Inc. April 26, 2024 Join
KIND Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II April 29, 2024 Join
PLCE The Children's Place, Inc. April 29, 2024 Join
SNOW Snowflake Inc. April 29, 2024 Join